Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

False or pirated antimalarial drugs freely obtainable in Cameroon

01.07.2004


Medical drug falsification mainly concerns those which are in high demand, such as antimalarials in African regions where malaria is endemic. IRD researchers (1) have examined the quality of antimalarial medicines available from informal distribution networks in Cameroon. They also assessed the impact of malaria patients’ taking these medicines, obtained on the illicit market, on their health. Self-medication is common but when it relies on supplies of poor-quality drugs it is ineffectual for controlling the disease. Quite the reverse, as it favours proliferation of treatment-resistant parasites leading to treatment failures and to people spending money futilely on health. Government measures for controlling such fraud are clearly necessary if public health is to be protected.

Large-scale diffusion and sale of medicines that do not comply with regulations or are poor in quality, especially in African countries, stems from several factors. These include: the intensification of trade, a growing demand for medical treatments or vaccines, a proliferation of small pharmaceutical industries, and inadequate regulation of manufacture and commerce of such products. Counterfeiting, which affects all classes of medical drugs, concerns mainly antibiotics and anti-parasitic drugs. This is the case of antimalarials, under high demand in African countries where malaria is endemic. This demand sustains the informal trade of false or poor quality antimalarial drugs, which is the final stage for distribution networks of counterfeit medicines that escape any control by health authorities.

To assess the effect this illegal sector has on malaria control, an IRD team investigated the origin and quality of several antimalarial drugs in tablet or capsule form. They were purported to contain chloroquine, quinine or a sulfadoxin-pyrimethamin mixture. These medicines were collected between 2001 and 2002 on the markets, from street vendors or patients who had obtained supplies from outside official networks, in several towns and villages in Cameroon.



A total of 284 samples obtained from 132 different points of sale in 16 localities were submitted to colorimetric tests and chromatographic analyses. The team succeeded in determining if the active principle contained in these medicines really corresponded to that for which they were being sold and approximately evaluate its quantity. They showed that 38% of the drugs supposedly containing chloroquine, 74% said to contain quinine and 12% of those purported to have sulfadoxin-pyrimethamin in fact contained either no active principle, one insufficient in quantity, or an active principle of another sort, or even some unknown compounds. Out of all the samples studied, only 118 bore mention of their origin, 61 coming from the European Union, 6 from East Europe, 39 from Asia and 12 from Africa. In most cases it was impossible to determine the names of pharmaceutical companies responsible either for marketing or for their manufacture. Other analyses were conducted on 15 samples sold purportedly containing chloroquine and quinine, samples collected from 15 patients who had acquired them on the informal market, without prior consultation. Only six of these samples proved to be of acceptable quality. Eight among the 15 patients gave negative urine tests for the active principle. Such absence of any trace of the latter results from self-medication with false drugs or under-dosed medicines with insufficient antimalarial active principle.

The illegal trade and free use of these non-compliant products can aggravate the clinical state of patients, possibly leading to death from the disease itself owing to the ineffectiveness of these treatments. These practices often induce a prolongation of treatment times which affects health expenditure. Moreover, they favour the selection of pathogens resistant to authentic antimalarial drugs, effectively holding back the actions of research and national malaria control programmes.

However, the practice of self-medication, on condition that it is based on medicines that comply with quality and dosage requirements, could represent a strategy for rapid, early intervention in case of malaria attack. Applied early, it could reduce the risk of patients’ deterioration towards the more severe forms of the disease. In Cameroon, as in most African countries, self-medication is common. People suffering from the disease avoid medical consultations because of their cost, often prohibitive for low-income households, and the absence of or distance from health care facilities. Obtaining such drugs on the informal market is cheaper than buying them from dispensaries authorized to issue medicines.

Government measures therefore appear necessary to provide better regulation of import and distribution of good quality generic medicines, fraud control and training (health authority personnel, pharmacists, medicines, etc.), in order to improve access to treatments, medical follow-up of patients and to contribute effectively to malaria control.

Bénédicte Robert | EurekAlert!
Further information:
http://www.ird.fr

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>